Ohio Public Employees Retirement System (OPERS)
DNA icon

Ohio Public Employees Retirement System (OPERS)’s Ginkgo Bioworks DNA Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,500
Closed -$126K – 2318
2026
Q1 		$126K Hold
20,500
– – ﹤0.01% 1750
2025
Q4 		$170K Buy
+20,500
New +$221K ﹤0.01% 1713
2024
Q2 		– Sell
-15,052
Closed -$698K – 1999
2024
Q1 		$698K Sell
15,052
-1,231
-8% -$63.7K ﹤0.01% 1191
2023
Q4 		$1.1M Buy
16,283
+649
+4% +$39.7K ﹤0.01% 1126
2023
Q3 		$1.13M Sell
15,634
-1,732
-10% -$138K 0.01% 1101
2023
Q2 		$1.29M Buy
17,366
+6,512
+60% +$385K 0.01% 1111
2023
Q1 		$577K Sell
10,854
-337
-3% -$21.4K ﹤0.01% 1248
2022
Q4 		$756K Buy
11,191
+895
+9% +$82.3K ﹤0.01% 1216
2022
Q3 		$1.28M Buy
10,296
+81
+0.8% +$9.65K 0.01% 1161
2022
Q2 		$972K Buy
+10,215
New +$1.25M ﹤0.01% 1247

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s DNA Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Ginkgo Bioworks (DNA) in Q2 2026, closing a stake of 20,500 shares — an estimated $126K sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in DNA in Q2 2022 and held it in 10 quarters. The position peaked at $1.29M in Q2 2023. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Ginkgo Bioworks position as of Q2 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 20,500 Ginkgo Bioworks shares in Q2 2026, an estimated $126K.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Ginkgo Bioworks in Q2 2022 and held it in 10 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Ginkgo Bioworks position peaked at $1.29M in Q2 2023.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.